Born: 1962.
Education: BSc. General Nursing
Executive Diploma in Managing Medical Product Innovation (MMPI). CBS Executive, Copenhagen Business School, Denmark. Master Certificate in Project Management, The George Washington University School of Business, Washington DC, USA.
Other current appointments: Senior Project Manager, KLIFO A/S, Denmark
Work experience: Having worked at major global pharmaceutical companies, small biotech and CROs in Sweden, Denmark, Malaysia and US, Stefan has 30 years of experience working with clinical development/clinical trials. Stefan´s work has mainly been focused on all aspects of clinical operations e.g., clinical trial management including budget, timelines resources, sponsor oversight, authoring protocol and informed consent, development study-specific documents, team training, data cleaning, and patient recruitment, but also line management, clinical quality and education.
Member of:
PharmNovo is very pleased to announce that we have been awarded a 2.5 MEUR grant and an opportunity for up to 15 MEUR equity investment from the European Innovation Council (EIC) for innovative pain treatment. The equity part being contingent on investments of equal amounts from co-investors.
Read moreOn May 29–30, BioStock hosted the Global Forum. The event is the first of its kind, aimed at bringing together growth stage Nordic life science companies looking to expand into new markets and experts armed with a profound knowledge of how business is done across the globe.
Read moreThe final results from the Phase I clinical for our neuropathic pain drug candidate PN6047, demonstrates safety and tolerability and a lack of the adverse effects commonly associated with conventional opioids. The findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported.
Read moreBengt von Mentzer founded PharmNovo 16 years ago, and today, his visionary approach and scientific process still drive the development of the groundbreaking compound PN6047. At the intersection of innovation and scientific leadership, Bengt von Mentzer is paving the way for how to reshape the landscape of chronic pain treatment.
Read more